REALITY TV
TV
MOVIES
MUSIC
CELEBRITY
About Us Contact Us Privacy Policy Terms of Use Accuracy & Fairness Corrections & Clarifications Ethics Code Your Ad Choices
© MEAWW All rights reserved
MEAWW.COM / NEWS / HUMAN INTEREST

Bernie Sanders slams pharmaceutical company charging $375K for a drug which was free for years

Sanders asked Catalyst Pharmaceuticals explain both the financial and non-financial factors the company considered when it set the list price for Firdapse in December.
PUBLISHED FEB 5, 2019

United States Senator Bernie Sanders slammed Catalyst Pharmaceuticals on Monday in a letter, asking the firm to justify their decision of charging $375,000 annually for a drug which was available to patients for free for years.

Sanders asked the firm to explain both the financial and non-financial factors the company considered when it set the list price for Firdapse in December, according to reports. Sanders' letter was reportedly dated February 4. Fidapse is reportedly used to treat a rare neuromuscular disorder called the Lambert-Eaton Myasthenic Syndrome (LEMS), and in which the immune system attacks the body's own tissues. The disorder affects nearly one in 100,000 people in the US.

RELATED TOPICS FLORIDA NEWS NEW JERSEY (NJ) NEWS
POPULAR ON MEAWW
MORE ON MEAWW